Bioconjugation

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Bioconjugation is the chemical strategy that forms a stable covalent link between two biomolecules.

Function[edit]

Recent advances in the understanding of biomolecules enabled their application to numerous fields like medicine and materials. Synthetically modified biomolecules can have diverse functionalities, such as tracking cellular events, reveal enzyme function, determining protein biodistribution, imaging specific biomarkers, and delivering drugs to targeted cells.[1][2][3][4] Bioconjugation is a crucial strategy that links these modified biomolecules with different substrates.

Synthesis[edit]

Synthesis of bioconjugates involves a variety of challenges, ranging from the simple and nonspecific use of a fluorescent dye marker to the complex design of antibody drug conjugates.[1][3] As a result, various bioconjugation reactions – chemical reactions connecting two biomolecules together – have been developed to chemically modify proteins. Common types of bioconjugation reactions are coupling of lysine amino acid residues, coupling of cysteine residues, coupling of tyrosine residues, modification of tryptophan residues, and modification of the N- and C- terminus.[1][3][4]

However, these reactions often lack chemoselectivity and efficiency, because they depend on the presence of native amino acid residues, which are usually present in large quantities that hinder selectivity. There is an increasing need for chemical strategies that can effectively attach synthetic molecules site specifically to proteins. One strategy is to first install a unique functional group onto a protein, and then a bioorthogonal or click type reaction is used to couple a biomolecule with this unique functional group.[1] The bioorthogonal reactions targeting non-native functional groups are widely used in bioconjugation chemistry. Some important reactions are modification of ketone and aldehydes, Staudinger ligation with azides, copper-catalyzed huisgen cyclization of azide, strain promoted huisgen cyclization of azide.[5][6][7][8]

Common Bioconjugation reactions[edit]

The most common bioconjugations are coupling of a small molecule (such as biotin or a fluorescent dye) to a protein, or protein-protein conjugations, such as the coupling of an antibody to an enzyme. Other less common molecules used in bioconjugation are oligosaccharides, nucleic acids, synthetic polymers such as polyethylene glycol,[9] and carbon nanotubes.[10] Antibody-drug conjugates such as Brentuximab vedotin and Gemtuzumab ozogamicin are also examples of bioconjugation, and are an active area of research in the pharmaceutical industry.[11] Recently, bioconjugation has also gained importance in nanotechnology applications such as bioconjugated quantum dots.

Reactions of lysine residues[edit]

The nucleophilic lysine residue is commonly targeted site in protein bioconjugation, typically through amine-reactive succinimidyl esters.[3] To obtain optimal number of deprotonated lysine residues, the pH of the aqueous solution must be below the pKa of the lysine ammonium group, which is around 10.5, so the typical pH of the reaction is about 8 and 9. The common reagent for the coupling reaction is NHS-ester (shown in the first reaction below in Figure 1), which reacts with nucleophilic lysine through a lysine acylation mechanism. Other similar reagents are isocyanates and isothiocyanates that undergo a similar mechanism (shown in the second and third reactions in Figure 1 below).[1]

Figure 1. Bioconjugation strategies for lysine residues.jpg

Reactions of cysteine residues[edit]

Because free cysteine rarely occurs on protein surface, it is an excellent choice for chemoselective modification. Under basic condition, the cysteine residues will be deprotonated to generate a thiolate nucleophile, which will react with soft electrophiles, such as maleimides and iodoacetamides (shown in the first two reactions in Figure 2 below). As a result, a carbon-sulfur bond is formed. Another modification of cysteine residues involves the formation of disulfide bond (shown in the second two reactions in Figure 2). The reduced cysteine residues react with exogenous disulfides, generating new disulfides bond on protein. An excess of disulfides is often used to drive the reaction, such as 2-thiopyridone and 3-carboxy-4-nitrothiophenol.[1][3]

Figure 2. Bioconjugation strategies for cysteine residues.jpg

Reactions of Tyrosine residues[edit]

Tyrosine residues are relatively unreactive; therefore they have not been a popular targets for bioconjugation. Recent development has shown that the tyrosine can be modified through electrophilic aromatic substitutions (EAS) reactions, and it is selective for the aromatic carbon adjacent to the phenolic hydroxyl group.[1] This becomes particularly useful in the case that cysteine residues cannot be targeted. Specifically, diazonium effectively couples with tyrosine residues (diazonium salt shown as catalyst in Figure 3 below), and an electron withdrawing substituent in the 4-position of diazonium salt can effectively increase the efficiency of the reaction.

Figure 3. Bioconjugation strategies for tyrosine residues.jpg

Reactions of N- and C- termini[edit]

Since natural amino acid residues are usually present in large quantities, it is often difficult to modify one single site. Strategies targeting the termini of protein have been developed, because they greatly enhanced the site selectivity of protein modification. One of the N- termini modifications involves the functionalization of the terminal amino acid. The oxidation of N-terminal serine and threonine residues are able to generate N-terminal aldehyde, which can undergo further bioorthogonal reactions (shown in the first reaction in Figure 4). Another type of modification involves the condensation of N-terminal cysteine with aldehyde, generating thiazolidine that is stable at high pH (second reaction in Figure 4). Using pyridoxal phosphate (PLP), several N-terminal amino acids can undergo transamination to yield N-terminal aldehyde, such as glycine and aspartic acid (third reaction in Figure 4).

Figure 4. Bioconjugation strategies for N-terminus.jpg

An example of C-termini modification is the native chemical ligation (NCL), which is the coupling between a C-terminal thioester and a N-terminal cysteine (Figure 5).

Figure 5. Bioconjugation strategies for C-terminus.jpg

Bioorthogonal reactions[edit]

Modification of ketones and aldehydes[edit]

A ketone or aldehyde can be attached to a protein through the oxidation of N-terminal serine residues or transamination with PLP. Additionally, they can be introduced by incorporating unnatural amino acids via the Tirrell method or Schultz method.[5] They will then selectively condense with an alkoxyamine and a hydrazine, producing oxime and hydrazone derivatives (shown in the first and second reactions, respectively, in Figure 6). This reaction is highly chemoselective in terms of protein bioconjugation, but the reaction rate is slow. The mechanistic studies show that the rate determining step is the dehydration of tetrahedral intermediate, so a mild acidic solution is often employed to accelerate the dehydration step.[2]

Figure 6. Bioconjugation strategies for targeting ketones and aldehydes.jpg

The introduction of nucleophilic catalyst can significantly enhance reaction rate (shown in Figure 7). For example, using aniline as a nucleophilic catalyst, a less populated protonated carbonyl becomes a highly populated protonated Schiff base.[12] In other words, it generates a high concentration of reactive electrophile. The oxime ligation can then occur readily, and it has been reported that the rate increased up to 400 times under mild acidic condition.[12] The key of this catalyst is that it can generate a reactive electrophile without competing with desired product.

Figure 7. Nucleophilic catalysis of oxime ligation.jpg

Staudinger Ligation with Azides[edit]

The Staudinger ligation of azides and phosphine has been used extensively in field of chemical biology. Because it is able to form a stable amide bond in living cells and animals, it has been applied to modification of cell membrane, in vivoimaging, and other bioconjugation studies.[13][14][15][16]


Figure 8. Staudinger Ligation with Azides.jpg

Contrasting with the classic Staudinger reaction, Staudinger ligation is a second order reaction in which the rate-limiting step is the formation of phosphazide (specific reaction mechanism shown in Figure 9). The triphenylphosphine first reacts with the azide to yield an azaylide through a four-membered ring transition state, and then an intramolecular reaction leads to the iminophosphorane intermediate, which will then give the amide-linkage under hydrolysis.[17]

Figure 9. Mechanism of Staudinger Ligation.jpg

Huisgen Cyclization of Azides[edit]

Main article: Huisgen cycloaddition
Copper catalyzed Huisgen Cyclization of Azides[edit]

Azide has become a popular target for chemoselective protein modification, because they are small in size and has a favorable thermodynamic reaction potential. One such azide reactions is the [3+2] cycloaddition reaction with alkyne, but the reaction requires high temperature and often gives mixtures of regioisomers.

Figure 10. Copper-catalyzed cyclization of Azides.jpg

An improved reaction developed by chemist Karl Barry Sharpless involves the copper (I) catalyst, which couples azide with terminal alkyne that only give 1,4 substituted 1,2,3 triazoles in high yields (shown below in Figure 11). The mechanistic study suggests a stepwise reaction.[8] The Cu (I) first couples with acetylenes, and then it reacts with azide to generate a six-membered intermediate. The process is very robust that it occurs at pH ranging from 4 to 12, and copper (II) sulfate is often used as a catalyst in the presence of a reducing agent.[8]

Figure 11. Mechanism for Copper-catalyzed cyclization of Azides.jpg

Strain Promoted Huisgen Cyclization of Azides[edit]

Even though Staudinger ligation is a suitable bioconjugation in living cells without major toxicity, the phosphine’s sensitivity to air oxidation and its poor solubility in water significantly hinder its efficiency. The copper (I) catalyzed azide-alkyne coupling has reasonable reaction rate and efficiency under physiological conditions, but copper poses significant toxicity and sometimes interferes with protein functions in living cells. In 2004, chemist Carolyn R. Bertozzi’s lab developed a metal free [3+2] cycloaddition using strained cyclooctyne and azide. Cyclooctyne, which is the smallest stable alkyne, can couple with azide through [3+2] cycloaddition, leading to two regioisomeric triazoles (Figure 12).[6] The reaction occurs readily in room temperature and therefore can be used to effectively modify living cells without negative effects. It has also been reported that the installation of fluorine substituents on cyclic alkyne can greatly accelerate the reaction rate.[2][18]

Figure 12. Strain promoted cycloaddition of azides and cyclooctynes.jpg

See also[edit]

References[edit]

  1. ^ a b c d e f g Stephanopoulos, N.; Francis, M. B. (2011). "Choosing an effective protein bioconjugation strategy". Nature Chemical Biology 7 (12): 876–884. doi:10.1038/nchembio.720. PMID 22086289.  edit
  2. ^ a b c Tilley, S. D.; Joshi, N. S.; Francis, M. B. (2008). "Wiley Encyclopedia of Chemical Biology". doi:10.1002/9780470048672.wecb493. ISBN 0470048670.  |chapter= ignored (help) edit
  3. ^ a b c d e Francis, M. B.; Carrico, I. S. (2010). "New frontiers in protein bioconjugation". Current Opinion in Chemical Biology 14 (6): 771–773. doi:10.1016/j.cbpa.2010.11.006. PMID 21112236.  edit
  4. ^ a b Kalia, J.; Raines, R. T. (2010). "Advances in Bioconjugation". Current organic chemistry 14 (2): 138–147. PMC 2901115. PMID 20622973.  edit
  5. ^ a b Carrico, I. S.; Carlson, B. L.; Bertozzi, C. R. (2007). "Introducing genetically encoded aldehydes into proteins". Nature Chemical Biology 3 (6): 321–322. doi:10.1038/nchembio878. PMID 17450134.  edit
  6. ^ a b Agard, N. J.; Prescher, J. A.; Bertozzi, C. R. (2004). "A Strain-Promoted \3 + 2] Azide−Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living Systems". Journal of the American Chemical Society 126 (46): 15046–15047. doi:10.1021/ja044996f. PMID 15547999.  edit
  7. ^ Kolb, H. C.; Finn, M. G.; Sharpless, K. B. (2001). "Click Chemistry: Diverse Chemical Function from a Few Good Reactions". Angewandte Chemie International Edition 40 (11): 2004–2021. doi:10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5. PMID 11433435.  edit
  8. ^ a b c Rostovtsev, Vsevolod V.; Green, Luke G.; Fokin, Valery V.; Sharpless, K. Barry (2002). "A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective "Ligation" of Azides and Terminal Alkynes". Angewandte Chemie International Edition 41 (14): 2596–2599. doi:10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4. ISSN 1433-7851. PMID 12203546. 
  9. ^ Thordarson, P., B. Le Droumaguet, K. Velonia (2006). "Well-defined protein– polymer conjugates—synthesis and potential applications." Applied Microbiology and Biotechnology 73(2): 243-254. http://www.springerlink.com/content/u8445242300333u6/?p= 960b3133ca044820889cc539373d40e1&pi=0

  10. ^ Yang, W., P. Thordarson, et al. (2007). "Carbon nanotubes for biological and biomedical applications." Nanotechnology 18(41). http://www.iop.org/EJ/abstract/0957- 4484/18/41/412001

  11. ^ Gerber HP, Senter PD, Grewal IS (2009). "Antibody drug-conjugates targeting the tumor vasculature: Current and future developments". MAbs 1 (3): 247–53. doi:10.4161/mabs.1.3.8515. PMID 20069754.
  12. ^ a b Dirksen, A.; Hackeng, T. M.; Dawson, P. E. (2006). "Nucleophilic Catalysis of Oxime Ligation". Angewandte Chemie International Edition 45 (45): 7581–4. doi:10.1002/anie.200602877. PMID 17051631.  edit
  13. ^ Lemieux, G. A.; De Graffenried, C. L.; Bertozzi, C. R. (2003). "A Fluorogenic Dye Activated by the Staudinger Ligation". Journal of the American Chemical Society 125 (16): 4708–4709. doi:10.1021/ja029013y. PMID 12696879.  edit
  14. ^ Laughlin, S. T.; Baskin, J. M.; Amacher, S. L.; Bertozzi, C. R. (2008). "In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish". Science 320 (5876): 664–667. doi:10.1126/science.1155106. PMC 2701225. PMID 18451302.  edit
  15. ^ Saxon, E.; Bertozzi, C. R. (2000). "Cell Surface Engineering by a Modified Staudinger Reaction". Science 287 (5460): 2007–2010. doi:10.1126/science.287.5460.2007. PMID 10720325.  edit
  16. ^ Prescher, J. A.; Dube, D. H.; Bertozzi, C. R. (2004). "Chemical remodelling of cell surfaces in living animals". Nature 430 (7002): 873–877. doi:10.1038/nature02791. PMID 15318217.  edit
  17. ^ Lin, F. L.; Hoyt, H. M.; Van Halbeek, H.; Bergman, R. G.; Bertozzi, C. R. (2005). "Mechanistic Investigation of the Staudinger Ligation". Journal of the American Chemical Society 127 (8): 2686–2695. doi:10.1021/ja044461m. PMID 15725026.  edit
  18. ^ Chang, P. V.; Prescher, J. A.; Sletten, E. M.; Baskin, J. M.; Miller, I. A.; Agard, N. J.; Lo, A.; Bertozzi, C. R. (2010). "Copper-free click chemistry in living animals". Proceedings of the National Academy of Sciences 107 (5): 1821. doi:10.1073/pnas.0911116107.  edit